Virtu Financial LLC Purchases Shares of 30,951 DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Virtu Financial LLC purchased a new stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) during the 1st quarter, HoldingsChannel.com reports. The institutional investor purchased 30,951 shares of the medical instruments supplier’s stock, valued at approximately $1,027,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Nuance Investments LLC grew its holdings in DENTSPLY SIRONA by 30.4% during the fourth quarter. Nuance Investments LLC now owns 11,603,889 shares of the medical instruments supplier’s stock valued at $412,982,000 after purchasing an additional 2,702,457 shares during the last quarter. First Eagle Investment Management LLC grew its stake in shares of DENTSPLY SIRONA by 1.2% in the fourth quarter. First Eagle Investment Management LLC now owns 9,786,845 shares of the medical instruments supplier’s stock worth $348,314,000 after acquiring an additional 120,508 shares during the last quarter. Wellington Management Group LLP grew its stake in shares of DENTSPLY SIRONA by 21.1% in the fourth quarter. Wellington Management Group LLP now owns 8,138,253 shares of the medical instruments supplier’s stock worth $289,640,000 after acquiring an additional 1,419,503 shares during the last quarter. Cooke & Bieler LP grew its stake in shares of DENTSPLY SIRONA by 18.3% in the fourth quarter. Cooke & Bieler LP now owns 7,061,910 shares of the medical instruments supplier’s stock worth $251,333,000 after acquiring an additional 1,092,922 shares during the last quarter. Finally, Generation Investment Management LLP grew its stake in shares of DENTSPLY SIRONA by 43.4% in the fourth quarter. Generation Investment Management LLP now owns 6,598,211 shares of the medical instruments supplier’s stock worth $234,830,000 after acquiring an additional 1,998,012 shares during the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

DENTSPLY SIRONA Stock Down 4.6 %

Shares of NASDAQ XRAY opened at $25.49 on Friday. The stock has a market cap of $5.17 billion, a PE ratio of -57.93, a PEG ratio of 1.28 and a beta of 1.01. The business has a fifty day moving average of $26.18 and a two-hundred day moving average of $30.08. DENTSPLY SIRONA Inc. has a 52-week low of $23.94 and a 52-week high of $40.92. The company has a debt-to-equity ratio of 0.57, a quick ratio of 0.97 and a current ratio of 1.33.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings data on Wednesday, July 31st. The medical instruments supplier reported $0.49 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.01). The company had revenue of $984.00 million for the quarter, compared to the consensus estimate of $993.61 million. DENTSPLY SIRONA had a negative net margin of 4.75% and a positive return on equity of 11.86%. The firm’s revenue was down 4.3% compared to the same quarter last year. During the same period in the previous year, the business posted $0.51 earnings per share. As a group, equities research analysts expect that DENTSPLY SIRONA Inc. will post 1.99 earnings per share for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 11th. Investors of record on Friday, September 27th will be issued a $0.16 dividend. The ex-dividend date is Friday, September 27th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 2.51%. DENTSPLY SIRONA’s dividend payout ratio is -145.45%.

Analyst Ratings Changes

XRAY has been the topic of several research analyst reports. The Goldman Sachs Group lowered their price objective on shares of DENTSPLY SIRONA from $34.00 to $30.00 and set a “neutral” rating on the stock in a research note on Monday, May 6th. Evercore ISI lowered their price objective on shares of DENTSPLY SIRONA from $28.00 to $27.00 and set an “outperform” rating on the stock in a research note on Tuesday, July 9th. Barrington Research restated an “outperform” rating and issued a $38.00 price objective on shares of DENTSPLY SIRONA in a research note on Monday, July 8th. Stifel Nicolaus decreased their price target on shares of DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating on the stock in a research note on Thursday, July 18th. Finally, Needham & Company LLC decreased their price target on shares of DENTSPLY SIRONA from $36.00 to $34.00 and set a “buy” rating on the stock in a research note on Wednesday. Five investment analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $33.44.

Insider Activity at DENTSPLY SIRONA

In other DENTSPLY SIRONA news, Director Gregory T. Lucier purchased 3,577 shares of the business’s stock in a transaction that occurred on Friday, May 31st. The stock was acquired at an average cost of $27.95 per share, with a total value of $99,977.15. Following the completion of the acquisition, the director now directly owns 58,374 shares of the company’s stock, valued at approximately $1,631,553.30. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.52% of the stock is currently owned by company insiders.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.